04 Jun June 4, 2018
S&P: CMS' 340B Rule Could Hurt Many Hospitals; HRSA Delays Drug Company Penalties Standard and Poor says CMS cuts to 340B drugs could force smaller, rural, and high DSH covered entities to serve fewer patients and create a huge strain on emergency departments. The report states,...